Blog
RSS FeedPosted by Michael Wonder on 29 Jul 2021
Cancer patients, advocates 'gobsmacked' PHARMAC declining funding application for life-changing drug
29 July 2021 - Ovarian cancer patients and advocates are "utterly gobsmacked" Pharmac has proposed to decline a funding application ...
Posted by Michael Wonder on 19 Jul 2021
Decision to widen access to rituximab for people with B-cell acute lymphoblastic leukaemia/lymphoma
9 July 2021 - PHARMAC is widening access to rituximab (Riximyo) to include treatment of people with newly diagnosed B-cell ...
Posted by Michael Wonder on 14 Jul 2021
No more sending Kiwis across the ditch as new national neuroendocrine cancer treatment service opens
14 July 2021 - The opening of a new multimillion dollar national service to treat neuroendocrine cancer means patients will ...
Posted by Michael Wonder on 05 May 2021
'Intimidating' PHARMAC move may lead to child cancer drug delays
6 May 2021 - Two of New Zealand's leading cancer experts have slammed PHARMAC's proposal to take away the special exemption ...
Posted by Michael Wonder on 04 May 2021
New Zealand ‘falling behind’ in lung cancer treatment
4 May 2021 - New Zealand employs a third world approach to the detection, treatment and care of lung cancer, ...
Posted by Michael Wonder on 03 May 2021
PHARMAC likely to end blanket funding for kids’ cancer drugs
3 May 2021 - A woman trying to get drugs funded for young spinal muscular atrophy patients was horrified when PHARMAC ...
Posted by Michael Wonder on 08 Apr 2021
Grant Robertson says Government focused on PHARMAC solution to cancer treatment
8 April 2021 - A woman who has had cancer says heartbreak has turned to anger at the way she ...
Posted by Michael Wonder on 07 Mar 2021
Cancer Society says PHARMAC review doesn't go far enough
3 March 2021 - A review of drug buying agency PHARMAC is being described as long overdue. ...
Posted by Michael Wonder on 03 Mar 2021
Cancer patient told palliative care only option after being rejected PHARMAC funding
2 March 2021 - The drug-buying agency was placed under an independent review today after the Prime Minister said she ...
Posted by Michael Wonder on 07 Feb 2021
Timaru mother with terminal bowel cancer calling on Government to fund cetuximab
5 February 2020 - A terminally ill woman shelling out more than $12,000 a year for extra time with her ...
Posted by Michael Wonder on 01 Feb 2021
Patient advocate slams cancer agency report over 'wall of silence' on PHARMAC funding
2 February 2021 - The Cancer Control Agency has released its first report into cancer in New Zealand, but one patient ...
Posted by Michael Wonder on 21 Dec 2020
Kiwis going into debt to pay for drugs other countries fund
21 December 2020 - An internal stoush at the drug-buying agency PHARMAC has blocked funding for a life-extending drug for bowel ...
Posted by Michael Wonder on 09 Dec 2020
'We're feeling broken': Taranaki father of six dies after battle for cancer drug funding
10 December 2020 - A Taranaki father who fought to get vital cancer drugs funded by the Government has lost his ...
Posted by Michael Wonder on 23 Nov 2020
Woman trying to raise $110,000 a month for life-extending breast cancer treatment
23 November 2020 - “Pay up or die” is the choice for a woman in her 30s trying to raise ...
Posted by Michael Wonder on 29 Oct 2020
PTAC recommends the reimbursement of osimertinib mesylate for the first-line treatment of patients with locally advanced or metastatic epidermal growth factor receptor mutated non-small cell lung cancer
29 October 2020 - PTAC has acknowledged the high unmet clinical need and the high quality, randomised control trial evidence ...